Abstract
Summary. Essential thrombocythemia (ЕТ) is a rare blood disorder associated with various thrombotic events. We present a clinical case of a female patient with ET, a patent foramen ovale, and transient ischemic attacks. In both ET and a patent foramen ovale, there may be concomitant risk factors for the development of thrombosis in various locations, including cerebral arteries. This highlights the need for detailed screening in young patients in this cohort.
For citation: Kuznetsova P.I., Chechetkin A.O., Raskurazhev A.A., Tanashyan M.M. Transient ischemic attacks in a female patient with a patent foramen ovale and essential thrombocythemia. Tromboz, gemostaz i reologiya. 2024;(2):82–86. (In Russ.).
References
- Tefferi A., Pardanani A. Essential thrombocythemia. N Engl J Med. 2019;381(22):2135–44. DOI: 10.1056/NEJMcp1816082.<?
- El Jahrani N., Cretin G., de Brevern A.G. CALR-ETdb, the database of calreticulin variants diversity in essential thrombocythemia. Platelets. 2022;33(1):157–67. DOI: 10.1080/09537104.2020.1869712.<?
- Szuber N., Mudireddy M., Nicolosi M. et al. 3023 Mayo Clinic patients with myeloproliferative neoplasms: risk-stratified comparison of survival and outcomes data among disease subgroups. Mayo Clin Proc. 2019;94(4):599–610. DOI: 10.1016/ j.mayocp.2018.08.022.<?
- Hagen P.T., Scholz D.G., Edwards W.D. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17–20. DOI: 10.1016/s0025-6196(12)60336-x.<?
- Elgendy A. Y., Saver J. L., Amin Z. et al. Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke. JAMA Neurol. 2020;77(7):878–86. DOI: 10.1001/jamaneurol.2020.0458.<?
- Yuan K., Kasner S.E. Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention. Stroke Vasc Neurol. 2018;3(2):84–91. DOI: 10.1136/svn-2018-000173.<?
- Mojadidi M.K., Winoker J.S., Roberts S.C. et al. Accuracy of conventional transthoracic echocardiography for the diagnosis of intracardiac right-to-left shunt: a meta-analysis of prospective studies. Echocardiography. 2014;31(9):1036–48. DOI: 10.1111/echo.12583.<?
- Pristipino C., Sievert H., D’Ascenzo F. et al; joint task force of European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Stroke Organisation (ESO), European Heart Rhythm Association (EHRA), European Association for Cardiovascular Imaging (EACVI), Association for European Paediatric and Congenital Cardiology (AEPC), ESC Working group on GUCH, ESC Working group on Thrombosis, European Haematological Society (EHA), European Underwater and Baromedical Society (EUBS). European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. EuroIntervention. 2019;14(13):1389– 402. DOI: 10.4244/EIJ-D-18-00622.<?
- Mojadidi M.K., Roberts S.C., Winoker J.S. et al. Accuracy of transcranial Doppler for the diagnosis of intracardiac right-to-left shunt: a bivariate meta-analysis of prospective studies. JACC Cardiovasc Imaging. 2014;7(3):236–50. DOI: 10.1016/j.jcmg.2013.12.011.<?
- Jauss M., Zanette E. Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis. 2000;10(6):490–6. DOI: 10.1159/000016119.<?
- Ali Z.A., Karimi Galougahi K., Maehara A. et al. Intracoronary optical coherence tomography 2018: current status and future directions. JACC Cardiovasc Interv. 2017;10(24):2473–87. DOI: 10.1016/j. jcin.2017.09.042.<?
- Mojadidi M.K., Zaman M.O., Elgendy I.Y. et al. Cryptogenic stroke and patent foramen ovale. J Am Coll Cardiol. 2018;71(9):1035–43. DOI: 10.1016/j.jacc.2017.12.059.<?
- Yan C., Li H. Preliminary investigation of in situ thrombus within patent foramen ovale in patients with and without stroke. JAMA. 2021;325(20):2116–8. DOI: 10.1001/jama.2021.4359.<?
- Tan J.-S., Yan X.-X., Gao X. et al. Thrombus straddling a patent foramen ovale in a patient with pulmonary embolism related to essential thrombocythemia. Int J Hematol. 2021;113(2):159–60. DOI: 10.1007/s12185-020-03033-2.<?
- KuznetsovaP.I., RaskurazhevA.A., KonovalovR.N. et al. Covert brain infarcts in patients with Philadelphia chromosomenegative myeloproliferative disorders. J Clin Med. 2021;11(1):13. DOI: 10.3390/jcm11010013.<?
